[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 2 of about 2
1. Kumar N, Kohli M, Pandey S, Tulsi SP: Cystic hygroma. Natl J Maxillofac Surg; 2010 Jan;1(1):81-5
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The other treatment options are intralesional injection of OK-432, triamcinolone followed by surgical excision, if necessary, injection of sclerosing agents, repeated aspiration, radiotherapy and finally spontaneous regression without any form of treatment.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 22442559.001).
  • [ISSN] 0975-5950
  • [Journal-full-title] National journal of maxillofacial surgery
  • [ISO-abbreviation] Natl J Maxillofac Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  • [Other-IDs] NLM/ PMC3304185
  • [Keywords] NOTNLM ; Cystic hygroma / cavernous lymphangioma / spontaneous regression
  •  go-up   go-down


Advertisement
2. Gao Q, Wang C, Wen Y: [A study of effects of pingyangmycin injection on treatment of lymphangiomas in oral, maxillofacial and cervical regions]. Hua Xi Kou Qiang Yi Xue Za Zhi; 2002 Jun;20(3):184-6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [A study of effects of pingyangmycin injection on treatment of lymphangiomas in oral, maxillofacial and cervical regions].
  • OBJECTIVE: The purpose of this study was to investigate the indication and therapeutic effects of Pingyangmycin injection as a primary therapy of lymphangiomas in oral, maxillofacial and cervical region.
  • METHODS: A total of 195 patients (106 males and 89 females) with lymphangiomas in oral and maxillofacial regions were treated in the affiliated dental hospital of Sichuan University from May 1990 to December 2000.
  • The 200 lymphangiomas (5 patients had 2 lymphangiomas in different sites) underwent the therapy of Pingyangmycin, which was injected as with 1 mg/ml in saline.
  • RESULTS: The curative rate of cystic-type lymphangiomas was the highest.
  • Of the 51 cystic lymphangiomas, 110 capillary lymphangiomas, 18 cavernous lymphangiomas and 21 combinations of capillary and cavenous lymphangiomas, the curative rates were respectively 100% (51), 46.36% (51), 16.16% (3) and 19.05% (4), which showed a significant therapeutic effect, respectively.
  • CONCLUSION: The treatment of injection of Pingyangmycin is a selective primary method of lymphangiomas, which can reduce the size of lymphangiomas, and make them completely disappeared.
  • [MeSH-major] Antibiotics, Antineoplastic / administration & dosage. Bleomycin / administration & dosage. Bleomycin / analogs & derivatives. Head and Neck Neoplasms / drug therapy. Lymphangioma / drug therapy. Mouth Neoplasms / drug therapy. Tongue Neoplasms / drug therapy
  • [MeSH-minor] Adolescent. Adult. Child. Child, Preschool. Dexamethasone / administration & dosage. Drug Administration Schedule. Female. Humans. Infant. Injections, Intralesional. Male

  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • MedlinePlus Health Information. consumer health - Oral Cancer.
  • Hazardous Substances Data Bank. BLEOMYCIN .
  • Hazardous Substances Data Bank. DEXAMETHASONE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 12600061.001).
  • [ISSN] 1000-1182
  • [Journal-full-title] Hua xi kou qiang yi xue za zhi = Huaxi kouqiang yixue zazhi = West China journal of stomatology
  • [ISO-abbreviation] Hua Xi Kou Qiang Yi Xue Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Antibiotics, Antineoplastic; 11056-06-7 / Bleomycin; 77108-50-0 / zhengguangmycin; 7S5I7G3JQL / Dexamethasone
  •  go-up   go-down






Advertisement